"HIV Envelope Protein gp41/metabolism"[MeSH Terms] - Search Results

Year	Number of Results
1990	14
1991	10
1992	19
1993	37
1994	20
1995	25
1996	28
1997	21
1998	27
1999	27
2000	47
2001	34
2002	35
2003	47
2004	42
2005	35
2006	44
2007	55
2008	56
2009	41
2010	47
2011	68
2012	51
2013	54
2014	43
2015	38
2016	28
2017	28
2018	28
2019	34
2020	17
2021	18
2022	15
2023	6
2024	1

1

The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.

Lu W, Chen S, Yu J, Behrens R, Wiggins J, Sherer N, Liu SL, Xiong Y, Xiang SH, Wu L. Lu W, et al. J Virol. 2019 Mar 21;93(7):e02128-18. doi: 10.1128/JVI.02128-18. Print 2019 Apr 1. J Virol. 2019. PMID: 30651369 Free PMC article.

2

Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015).

Li W, Lu L, Li W, Jiang S. Li W, et al. Expert Opin Ther Pat. 2017 Jun;27(6):707-719. doi: 10.1080/13543776.2017.1281249. Epub 2017 Jan 19. Expert Opin Ther Pat. 2017. PMID: 28076686 Review.

3

Peptide-Based HIV Entry Inhibitors.

Pu J, Wang Q, Jiang S. Pu J, et al. Adv Exp Med Biol. 2022;1366:15-26. doi: 10.1007/978-981-16-8702-0_2. Adv Exp Med Biol. 2022. PMID: 35412132

4

HIV-1 fusion protein exerts complex immunosuppressive effects.

Ashkenazi A, Faingold O, Shai Y. Ashkenazi A, et al. Trends Biochem Sci. 2013 Jul;38(7):345-9. doi: 10.1016/j.tibs.2013.04.003. Epub 2013 May 17. Trends Biochem Sci. 2013. PMID: 23685134 Review.

5

Alterations in gp120 glycans or the gp41 fusion peptide-proximal region modulate the stability of the human immunodeficiency virus (HIV-1) envelope glycoprotein pretriggered conformation.

Zhang Z, Wang Q, Nguyen HT, Chen HC, Chiu TJ, Smith Iii AB, Sodroski JG. Zhang Z, et al. J Virol. 2023 Sep 28;97(9):e0059223. doi: 10.1128/jvi.00592-23. Epub 2023 Sep 11. J Virol. 2023. PMID: 37696048 Free PMC article.

6

Targeting HIV-1 gp41-induced fusion and pathogenesis for anti-viral therapy.

Garg H, Viard M, Jacobs A, Blumenthal R. Garg H, et al. Curr Top Med Chem. 2011 Dec;11(24):2947-58. doi: 10.2174/156802611798808479. Curr Top Med Chem. 2011. PMID: 22044225 Free PMC article. Review.

7

HIV entry and envelope glycoprotein-mediated fusion.

Blumenthal R, Durell S, Viard M. Blumenthal R, et al. J Biol Chem. 2012 Nov 30;287(49):40841-9. doi: 10.1074/jbc.R112.406272. Epub 2012 Oct 5. J Biol Chem. 2012. PMID: 23043104 Free PMC article. Review.

8

The frantic play of the concealed HIV envelope cytoplasmic tail.

Santos da Silva E, Mulinge M, Perez Bercoff D. Santos da Silva E, et al. Retrovirology. 2013 May 24;10:54. doi: 10.1186/1742-4690-10-54. Retrovirology. 2013. PMID: 23705972 Free PMC article. Review.

9

gp41: HIV's shy protein.

Zwick MB, Saphire EO, Burton DR. Zwick MB, et al. Nat Med. 2004 Feb;10(2):133-4. doi: 10.1038/nm0204-133. Nat Med. 2004. PMID: 14760422 Free PMC article.

10

Quaternary Interaction of the HIV-1 Envelope Trimer with CD4 and Neutralizing Antibodies.

Liu Q, Zhang P, Lusso P. Liu Q, et al. Viruses. 2021 Jul 20;13(7):1405. doi: 10.3390/v13071405. Viruses. 2021. PMID: 34372611 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

1,075 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

1,075 results

Results by year